• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善少女和年轻女性获取暴露前预防(PrEP)的机会:赞比亚“梦想”项目中基于社区的PrEP服务的描述性分析

Improving PrEP access for adolescent girls and young women: a descriptive analysis of community-based PrEP delivery in the DREAMS programme in Zambia.

作者信息

Musheke Maurice, Pry Jake M, Sikazwe Izukanji, Muyunda Walusiku J, Chiyenu Kanema, Siame Charity M, Khondowe Winfred K, Mushiki Bwalya, Mwaba Martha M, Zulu Pelile, Mwape Flavia, Siamasuku Bridget, Shula Davies, Mweemba Mable B, Kanene Cuthbert, Phiri Arlene, Herce Michael E

机构信息

Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

School of Medicine, University of California, Davis, California, USA.

出版信息

J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26484. doi: 10.1002/jia2.26484.

DOI:10.1002/jia2.26484
PMID:40622362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12232481/
Abstract

INTRODUCTION

Despite being at high risk of HIV acquisition, access to pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) is low in Zambia because PrEP is traditionally delivered in clinical settings. We describe the effects of community centres supported by the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) initiative on PrEP outcomes in Zambia and examine factors associated with PrEP continuation.

METHODS

We collected individual-level PrEP data for AGYW aged 15-24 years at risk of HIV acquisition and enrolled in DREAMS in seven districts of Zambia between August 2022 and August 2024. We used Pearson's Chi-squared test to examine differences in beneficiary characteristics between clients with a PrEP initiation visit and ≥ 2 PrEP visits (i.e. an initiation plus ≥ 1 return visit), and mixed effects Poisson regression modelling to estimate the association between DREAMS enrolment criteria and PrEP continuation (defined as ≥ 1 PrEP visit within 180 days of initiation). We also estimated the marginal probability of PrEP continuation by number of DREAMS enrolment criteria and used Kaplan-Meier methods to estimate the time to the first PrEP return visit by client age band.

RESULTS

Between 11 August 2022 and 23 August 2024, 15,502 AGYW aged 15-24 years were screened for PrEP eligibility, of whom 15,072 (97.2%) initiated PrEP per national guidelines. Of those initiating PrEP, 9807 (65.1%) had sufficient follow-up time to allow for observation of a PrEP return visit. The proportion of AGYW who had ≥ 1 PrEP return visit within 180 days of initiation was 59.0% (n/N = 5706/9675). Across age bands, the percent probability of having a PrEP return visit within 180 days of initiation was highest among clients who reported ≥ 4 DREAMS enrolment criteria at 91.7% (95% CI: 70.7, 112.7%) for clients aged 15-19 years and 83.6% (95% CI: 61.1, 106.2%) for clients aged 20-24 years. Overall, 41.5% of clients had a first PrEP return visit between 21 and 42 days of PrEP initiation.

CONCLUSIONS

The high number and proportion of AGYW initiated on PrEP suggests that decentralising PrEP services to DREAMS community centres has the potential to improve PrEP access among AGYW. Increasing HIV risk perception among AGYW may improve PrEP continuation.

摘要

引言

尽管青春期女孩和年轻女性(AGYW)感染艾滋病毒的风险很高,但在赞比亚,她们获得暴露前预防(PrEP)的机会却很低,因为传统上PrEP是在临床环境中提供的。我们描述了由“坚定、坚韧、赋权、无艾滋病、受指导和安全”(DREAMS)倡议支持的社区中心对赞比亚PrEP结果的影响,并研究了与PrEP持续使用相关的因素。

方法

我们收集了2022年8月至2024年8月期间在赞比亚七个地区有感染艾滋病毒风险且参加了DREAMS的15至24岁AGYW的个人层面PrEP数据。我们使用Pearson卡方检验来检查进行PrEP初次就诊的客户与进行≥2次PrEP就诊(即一次初次就诊加≥1次复诊)的客户之间的受益特征差异,并使用混合效应泊松回归模型来估计DREAMS登记标准与PrEP持续使用(定义为在初次就诊后180天内进行≥1次PrEP就诊)之间的关联。我们还按DREAMS登记标准的数量估计了PrEP持续使用的边际概率,并使用Kaplan-Meier方法按客户年龄组估计首次PrEP复诊的时间。

结果

在2022年8月11日至2024年8月23日期间,对15502名15至24岁的AGYW进行了PrEP资格筛查,其中15072人(97.2%)按照国家指南开始使用PrEP。在开始使用PrEP的人中,9807人(65.1%)有足够的随访时间以观察到PrEP复诊。在开始使用PrEP后180天内进行≥1次PrEP复诊的AGYW比例为59.0%(n/N = 5706/9675)。在各个年龄组中,在开始使用PrEP后180天内进行PrEP复诊的概率在报告≥4条DREAMS登记标准的客户中最高,15至19岁的客户为91.7%(95%置信区间:70.7,112.7%),20至24岁的客户为83.6%(95%置信区间:61.1,106.2%)。总体而言,41.5%的客户在PrEP开始后的21至42天内进行了首次PrEP复诊。

结论

开始使用PrEP的AGYW数量众多且比例较高,这表明将PrEP服务下放到DREAMS社区中心有可能改善AGYW获得PrEP的机会。提高AGYW对艾滋病毒风险的认知可能会改善PrEP的持续使用情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/1cdc9839d7fc/JIA2-28-e26484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/3fb8a812ecfe/JIA2-28-e26484-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/6eee581faf61/JIA2-28-e26484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/7653f603d13c/JIA2-28-e26484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/1cdc9839d7fc/JIA2-28-e26484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/3fb8a812ecfe/JIA2-28-e26484-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/6eee581faf61/JIA2-28-e26484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/7653f603d13c/JIA2-28-e26484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7253/12232481/1cdc9839d7fc/JIA2-28-e26484-g002.jpg

相似文献

1
Improving PrEP access for adolescent girls and young women: a descriptive analysis of community-based PrEP delivery in the DREAMS programme in Zambia.改善少女和年轻女性获取暴露前预防(PrEP)的机会:赞比亚“梦想”项目中基于社区的PrEP服务的描述性分析
J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26484. doi: 10.1002/jia2.26484.
2
PrEP choice in the real world: Results of a prospective cohort study describing uptake and use patterns of oral PrEP and the dapivirine vaginal ring among women in sub-Saharan Africa.现实世界中的暴露前预防选择:一项前瞻性队列研究的结果,该研究描述了撒哈拉以南非洲女性口服暴露前预防药物和达匹韦林阴道环的接受情况及使用模式。
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26457. doi: 10.1002/jia2.26457.
3
Determinants of continuation on HIV pre-exposure propylaxis among female sex workers at a referral hospital in Uganda: a mixed methods study using COM-B model.乌干达一家转诊医院女性性工作者中接受HIV暴露前预防持续治疗的决定因素:一项使用COM-B模型的混合方法研究
BMC Public Health. 2025 Jan 14;25(1):143. doi: 10.1186/s12889-024-20975-y.
4
Online delivery of oral HIV pre- and post-exposure prophylaxis: findings from the ePrEP Kenya pilot.口服艾滋病毒暴露前和暴露后预防药物的在线配送:肯尼亚电子预防试点项目的结果
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26468. doi: 10.1002/jia2.26468.
5
Impact of changing pre-exposure prophylaxis regimens on retention among men who have sex with men in Hanoi, Vietnam (2020-2023): a cohort study.越南河内男男性行为者中暴露前预防方案变化对留存率的影响(2020 - 2023年):一项队列研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26478. doi: 10.1002/jia2.26478.
6
High acceptability, feasibility and sustainability of a direct-to-pharmacy differentiated PrEP delivery model in public health HIV clinics in Kenya: perspectives of PrEP clients and healthcare providers.肯尼亚公共卫生艾滋病毒诊所中直接面向药房的差异化暴露前预防(PrEP)服务模式具有高度可接受性、可行性和可持续性:PrEP服务对象及医疗服务提供者的观点
J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26442. doi: 10.1002/jia2.26442.
7
Brief Report: Effect of Improved Provider Communication and Adherence to Guidelines on PrEP Initiation in Kisumu Kenya.简短报告:肯尼亚基苏木地区改善医疗服务提供者沟通及遵循指南对暴露前预防用药启动的影响
J Acquir Immune Defic Syndr. 2025 Mar 1;98(3):252-256. doi: 10.1097/QAI.0000000000003567.
8
Transforming PrEP marketing: understanding the place of PrEP in the hearts and minds of adolescent girls and young women in sub-Saharan Africa.转变艾滋病暴露前预防(PrEP)的营销方式:了解PrEP在撒哈拉以南非洲地区少女和年轻女性心中的地位。
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26480. doi: 10.1002/jia2.26480.
9
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
10
A modified pharmacy provider-led delivery model of oral HIV pre- and post-exposure prophylaxis in Kenya: a pilot study extension.肯尼亚一种经改良的由药房提供者主导的口服艾滋病毒暴露前和暴露后预防交付模式:一项试点研究扩展
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26467. doi: 10.1002/jia2.26467.

本文引用的文献

1
Barriers to PrEP use and adherence among adolescent girls and young women in Eastern, Southern, and Western Africa: a scoping review.东非、南非和西非青少年女孩和年轻女性中预防艾滋病病毒暴露前预防(PrEP)使用及依从性的障碍:一项范围综述
BMC Womens Health. 2024 Dec 26;24(1):665. doi: 10.1186/s12905-024-03516-y.
2
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.双年度利纳卡帕韦或每日 F/TAF 用于预防 cisgender 女性中的 HIV。
N Engl J Med. 2024 Oct 3;391(13):1179-1192. doi: 10.1056/NEJMoa2407001. Epub 2024 Jul 24.
3
Programme science in action: lessons from an observational study of HIV prevention programming for key populations in Lusaka, Zambia.
行动中的项目科学:来自赞比亚卢萨卡针对关键人群的艾滋病毒预防规划的观察性研究的经验教训。
J Int AIDS Soc. 2024 Jul;27 Suppl 2(Suppl 2):e26237. doi: 10.1002/jia2.26237.
4
Fostering Access to PrEP Among Adolescent Girls and Young Women Aged 16 to 24 Years at High Risk of HIV Through the DREAMS Initiative in Four Districts in Zambia.通过赞比亚四个地区的“梦想倡议”,为有感染艾滋病毒高风险的 16 至 24 岁青少年女孩和年轻妇女提供接触预防的机会。
AIDS Educ Prev. 2023 Jul;35:52-66. doi: 10.1521/aeap.2023.35.suppA.52.
5
Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.乌干达坎帕拉地区,感染艾滋病毒风险较高的青少年女孩和年轻女性对口服暴露前预防的接受和坚持情况:一项关于经验、促进因素和障碍的定性研究。
BMC Womens Health. 2022 Nov 10;22(1):440. doi: 10.1186/s12905-022-02018-z.
6
PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.肯尼亚和南非青春期女孩和年轻女性中使用预防用抗逆转录病毒药物(PrEP)与 HIV 血清转化率:POWER 示范项目。
J Int AIDS Soc. 2022 Jul;25(7):e25962. doi: 10.1002/jia2.25962.
7
From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.从政策到实践:2017-2020 年美国总统艾滋病紧急救援计划支持的国家中青少年女孩和年轻妇女对暴露前预防的使用情况。
AIDS. 2022 Jun 15;36(Suppl 1):S15-S26. doi: 10.1097/QAD.0000000000003103.
8
The evolution of DREAMS: using data for continuous program improvement.DRREAMS 的演进:利用数据进行持续的项目改进。
AIDS. 2022 Jun 15;36(Suppl 1):S5-S14. doi: 10.1097/QAD.0000000000003158.
9
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.卡博特韦用于女性艾滋病毒 1 型的预防:来自 HPTN 084 的结果,一项 3 期、随机临床试验。
Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1.
10
Assessing the Vulnerability and Risks of Adolescent Girls and Young Women in East and Southern Africa: A Preliminary Review of the Tools in Use.评估东非和南部非洲少女及青年女性的脆弱性与风险:对现有工具的初步审查
Trop Med Infect Dis. 2021 Jul 15;6(3):133. doi: 10.3390/tropicalmed6030133.